FeesSafety
Pluang+

HighTower Advisors boosts Bitcoin ETF holdings 50% to $155M, signaling growing advisor demand.

Market News
10 Nov 2026, 20:04 WIB
Crypto Briefing
View Source
Bullish
HighTower Advisors boosts Bitcoin ETF holdings 50% to $155M, signaling growing advisor demand.

HighTower Advisors increased its Bitcoin ETF holdings by 50% in Q3 2026 to $155 million, reflecting a trend where financial advisors are becoming the main institutional buyers of Bitcoin ETFs. This shift comes as hedge funds and banks reduce their exposure. Advisors typically hold Bitcoin ETFs for long-term client portfolios, suggesting a stabilizing influence on the market. The rise in advisor demand could encourage broader investment in regulated crypto products. Upcoming filings will reveal if this trend continues.

HighTower Advisors' Bitcoin ETF holdings reached $155 million in Q3 2026, marking a 50% increase. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Nov 11, 2026 01:03 WIB: out of 50 major cryptocurrencies tradable on Pluang, 7 rose and 42 fell today. Notable movers include ONE (Harmony) with a price of Rp32 and a 20.17% increase, BAL (Balancer) at Rp16.297 up 11.14%, and EOS (EOS.IO) at Rp12.649 with an 8.13% rise.

More News

EssilorLuxottica reports total shares and voting rights as of October 31, 2026, with a 31% voting cap per shareholder.

EssilorLuxottica reports total shares and voting rights as of October 31, 2026, with a 31% voting cap per shareholder.

As of October 31, 2026, EssilorLuxottica disclosed its total number of shares at 464,247,548 and actual voting rights at 458,376,127 after deducting treasury shares. The company enforces a 31% voting rights cap per shareholder, as outlined in its sta...

Company Fundamentals
Neutral
1 hour ago
EssilorLuxottica reports 464 million shares and voting rights as of October 31, 2026, with a 31% voting cap.

EssilorLuxottica reports 464 million shares and voting rights as of October 31, 2026, with a 31% voting cap.

EssilorLuxottica disclosed its share capital and voting rights as of October 31, 2026, reporting 464,247,548 shares outstanding and 458,376,127 real voting rights excluding treasury shares. The company applies a 31% cap on voting rights per sharehold...

Company Fundamentals
Neutral
1 hour ago
Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

The global peptide therapeutics market is projected to grow from $112.2 billion in 2026 to $229.32 billion by 2036, at a CAGR of 7.4%. Growth is fueled by expanding use of GLP-1 and incretin therapies, advances in peptide engineering, new oncology ap...

Bullish
2 hours ago
Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37, a direct-to-patient clinical research site, was named a BioSpace 2027 Best Place to Work, recognized for its innovative culture and commitment to clinical quality. The company’s model brings clinical trials to patients' homes, improving a...

Others
Bullish
2 hours ago
New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

Book Leopard, a new AI software, enables authors and publishers to create professional-quality Amazon book marketing materials in seconds for a one-time fee of $49, drastically reducing costs from over $1,000 and weeks of waiting. The tool generates ...

Others
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App